Paediatric bone marrow mesenchymal stem cells support acute myeloid leukaemia cell survival and enhance chemoresistance via contact‐independent mechanism
British Journal of Haematology · 2025
DOI: 10.1111/bjh.19884 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Haematology, 2025. Verfasst von Alison Laing und 11 weiteren Autor:innen. Beteiligte Einrichtung: Paul O'Gorman Leukaemia Research Centre, School of Cancer Sciences, University of Glasgow, Glasgow, UK. Hauptthemen laut MEDLINE: Mesenchymal Stem Cells, Leukemia, Myeloid, Acute, Drug Resistance, Neoplasm, Bone Marrow Cells. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Yorkhill Leukaemia and Cancer Research Fund, NHS greater Glasgow & Clyde Research Endownment Fund, Ministry of Higher Education of the Arab Republic of Egypt.
Abstract (Originalsprache)
Children diagnosed with acute myeloid leukaemia (paediatric AML [pAML]) have limited treatment options and relapse rates due to chemoresistance and refractory disease are over 30%. Current treatment is cytotoxic and in itself has long‐lasting harsh side effects. New, less toxic treatments are needed. The bone marrow microenvironment provides chemoprotection to leukaemic cells through cell communication and interaction with mesenchymal stem cells (MSCs), but this is not well defined in pAML. Using primary patient material, we identify a cell contact‐independent mechanism of MSC‐mediated chemoprotection involving extrinsic soluble factors that is abrogated through inhibition of the JAK/STAT and ERK pathways.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Paul O'Gorman Leukaemia Research Centre, School of Cancer Sciences, University of Glasgow, Glasgow, UK.
- Wolfson Wohl Cancer Research Centre, School of Cancer Sciences, University of Glasgow, Glasgow, UK.
- Haematology Department, Queen Elizabeth University Hospital, Glasgow, UK.
- Clinical Pathology Department, Mansoura University, Mansoura, Egypt.
- Clinical Pathology Department, Zagazig University, Zagazig, Egypt.
- Cancer Research UK Scotland Institute, Garscube Estate, Glasgow, UK.
ORCID-Profile: Claire Schwab, Karen Keeshan
Förderung
- Yorkhill Leukaemia and Cancer Research Fund
- NHS greater Glasgow & Clyde Research Endownment Fund
- Ministry of Higher Education of the Arab Republic of Egypt
- Pfizer
Zitieren
APA
Laing, A., Elmarghany, A., Alghaith, A. A., Gouma, A., Stevens, T., Winton, A., Cassels, J., Clarke, C. J., Schwab, C., Harrison, C. J., Gibson, B., & Keeshan, K. (2025). Paediatric bone marrow mesenchymal stem cells support acute myeloid leukaemia cell survival and enhance chemoresistance via contact‐independent mechanism. British Journal of Haematology. https://doi.org/10.1111/bjh.19884
Vancouver
Laing A, Elmarghany A, Alghaith AA, Gouma A, Stevens T, Winton A, et al. Paediatric bone marrow mesenchymal stem cells support acute myeloid leukaemia cell survival and enhance chemoresistance via contact‐independent mechanism. British Journal of Haematology. 2025. doi:10.1111/bjh.19884
BibTeX
@article{Laing2025,
author = {Laing, Alison and Elmarghany, Ahmed and Alghaith, Arwa A and Gouma, Aya and Stevens, Thomas and Winton, Alexander and Cassels, Jennifer and Clarke, Cassie J and Schwab, Claire and Harrison, Christine J and Gibson, Brenda and Keeshan, Karen},
title = {Paediatric bone marrow mesenchymal stem cells support acute myeloid leukaemia cell survival and enhance chemoresistance via contact‐independent mechanism},
journal = {British Journal of Haematology},
year = {2025},
doi = {10.1111/bjh.19884}
}
EUVIMED